Tweet The escalating approach to MS was based on failure. Failure drug 1 go to drug 2, fail go to drug 3 and hope that its not too late to limit progression occurring. This is a problem of the softly softly approach but the we’ll wait until I feel I have to do something type…
Month: March 2026
EBV antibodies in CNS years before MS
Tweet I guesss you all know this, but here is an example of an EBV infection 16 years before MS developed. So what happens in the interviening time and why are things unnoticed. One element to this is neurological researve. So just like the pancreas you can loose stuff before you notice it as such…
I’ve Avoided these Pages
When a writer stops writing the reasons are usually pretty expected. Your mind suddenly goes blank and all of the topics that you had in the back of your head wiggling around go away or seem irrelevant or unimportant. I talked to my therapist about my lack of writing lately and she threw it back…
Close relatives of MS patients face 100 times higher risk of developing disorder
Close relatives of people with multiple sclerosis (MS) are 100 times more likely to develop the neurological disorder than the general population, according to a new analysis of GEMS data. Among participants in GEMS, a large-scale observational study assessing MS risk among family members, about half said they would participate in a clinical trial aimed…
Coping with MS means sometimes being inattentive to myself and others
It’s definitely dark and maybe even disturbing, but a book I have always enjoyed is Thomas Harris’ “The Silence of the Lambs.” If you’re unfamiliar with either the book or the movie, you’ve either been living a sheltered life or you need to find someone whose birth year starts with “1” to tell you about…
UC Davis Health named Center for Comprehensive MS Care
The National Multiple Sclerosis Society has designated UC Davis Health in California as a new Center for Comprehensive MS Care, recognizing its ability to provide coordinated, multidisciplinary care for people with multiple sclerosis (MS). The designation is part of the society’s Network of MS Healthcare Professionals, which highlights centers that meet specific standards for comprehensive…
In life with relapsing-remitting MS, I am my own best advocate
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Trial of novel autoimmune disease treatment ICP-538 launches in China
Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function of T-cells and B-cells, which are immune cells that play…
Late-onset MS linked to faster disability progression: Study
People with multiple sclerosis (MS) who experience their first symptoms after age 50 tend to have faster disability progression than those with earlier disease onset, according to a recent study. The also more commonly develop primary progressive MS (PPMS). In addition, late-onset MS was associated with a higher risk of reaching certain disability milestones and faster transition…
The lived reality of MS is more than the disease’s clinical definition
Multiple sclerosis (MS) is a chronic neurological condition wherein the immune system attacks the protective covering of nerves. This clinical definition accurately portrays the medical reality, but it doesn’t encapsulate the lived reality. It doesn’t account for the ways in which fatigue can feel like gravity doubling overnight with no warning, how cognitive fog can…